Physician profile
Katherine Mcdaniel
NPI 1447719141
$449.32
in general payments reported to CMS, 2019-2025
9 companies · $241 in 2025
The $241 reported for 2025 was more than what 85% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.71 · 2022: $16.81 · 2023: $82.94 · 2024: $85.62 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $175.86 | 2023-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Sage Therapeutics, LLC | $64.13 | 2024-2025 | Zurzuvae |
| Organon LLC | $54.67 | 2022-2023 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $45.81 | 2025 | Slynd |
| Supernus Pharmaceuticals, INC. | $28.26 | 2025 | Qelbree |
| Abbvie INC. | $22.71 | 2021 | |
| Dexcom, INC. | $20.06 | 2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $19.55 | 2023 | |
| Agile Therapeutics, INC. | $18.27 | 2024 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.